Drugs / EN3285
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00574860 | Dec 2007 → Jun 2009 | head and neck cancer, mucositis | Endo USA Inc., a Keenova Therapeutics Company | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EN3285 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00574860 ↗ |
| Known as | NAC ProGelz | “EN3285 (NAC ProGelz)” NCT00574860 ↗ |